Evidence map›Paper›PMID 42181075›Full record

ArticleMethodsX2026

Technical implementation for african pharmacogenetic studies on

Keneuoe Cecilia Nthontho, Leabaneng Tawe, Nduta Mugo, Rorisang Mabaka, Gianmarco Contino, Andrew Khulekani Ndlovu, Daniel Paul Morse, Giacomo Maria Paganotti

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in MethodsX, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Keneuoe Cecilia NthonthoSchool of Allied Health Professions, Faculty of Health Sciences, University of Botswana, Gaborone, Botswana.
Leabaneng TaweSchool of Allied Health Professions, Faculty of Health Sciences, University of Botswana, Gaborone, Botswana.
Nduta MugoDepartment of Cancer and Genomic Sciences, College of Medicine and Health, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK.
Rorisang MabakaDepartment of Biomedical Sciences, Faculty of Medicine, University of Botswana, Gaborone, Botswana.
Gianmarco ContinoDepartment of Cancer and Genomic Sciences, College of Medicine and Health, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK.
Andrew Khulekani NdlovuSchool of Allied Health Professions, Faculty of Health Sciences, University of Botswana, Gaborone, Botswana.
Daniel Paul MorseDepartment of Chemistry, US Naval Academy, Annapolis, MD 21402, USA.
Giacomo Maria PaganottiBotswana-University of Pennsylvania Partnership, Gaborone, Botswana.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Breast cancer remains the most common cancer affecting women globally, with a disproportionate impact on low- and middle-income countries (LMICs), where survival is poor despite lower incidence. Conducting molecular studies in these settings is often hampered by limited resources and technical challenges, particularly when using traditional DNA sources. This is also true for pharmacogenetic studies among Africans. For this, we propose novel

Indexed as

ARMS-PCRBreast cancerCYP2D6Formalin-fixed paraffin-embedded tissuesNested-PCRPharmacogeneticsRFLP

Identifiers

PMID42181075
PMCPMC13191098

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.